The Pharmacy Market Size was valued at USD 1015.5 Billion in 2022 and is projected to grow from USD 1062.2 Billion in 2023 to USD 1522.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.60% during the forecast period (2023 - 2032). Aging population, chronic diseases, technological advancements, expanding global healthcare expenditure, generic drugs, personalized medicine, increased focus on preventive care, growing e-commerce and online pharmacies, emerging markets, regulatory changes, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
An important factor driving the expansion of the pharmacy business is rising worldwide healthcare spending. More funding for healthcare from public and commercial sources has a knock-on effect on many facets of the pharmacy sector.
Greater emphasis on supplying essential medicines to the population with more financing for healthcare available, there is an increase in the demand for pharmaceuticals. Increased access to medications is made possible by rising global healthcare spending, especially in low-income and emerging nations where affordability previously could have been a barrier. The pharmacy industry immediately benefits from the increase in medicine demand, which boosts sales and revenue.
Healthcare infrastructure improvements, like those in hospitals, clinics, and pharmacies, are frequently a part of greater healthcare spending. The opening of new healthcare facilities expands the population's access to medical treatments and services. Due to the fact that these facilities need a consistent supply of medicines to fulfill the demands of the expanding patient base, this in turn stimulates the need for pharmacy goods and services.
A large amount of healthcare spending goes on research and development of new pharmaceutical goods, or research and development, or R&D. To find new drugs, enhance currently available drugs, and provide cutting-edge treatment choices, governments and business organizations fund research and development (R&D). By bringing innovative and cutting-edge pharmaceutical goods to the market and increasing the variety of available treatments and treatment choices, this investment in R&D propels the pharmacy market.
Workforce in Healthcare Increasing worldwide healthcare spending frequently results in a rise in the number of healthcare professionals, including physicians, nurses, and pharmacists. Pharmaceutical items must be consistently available to address the population's healthcare demands as the workforce expands. Pharmacies are essential in supporting the expanding healthcare workforce, providing pharmaceuticals to medical professionals, and generating demand for pharmacy goods.
Technology innovations that improve productivity, accuracy, and patient care in pharmacies include automated systems, electronic health records, and pharmacy management software. The demand for sophisticated pharmacy solutions is increased as a result of the integration of these technologies, which enhance drug management, inventory control, and patient safety.
Health insurance coverage is frequently expanded as a result of rising healthcare costs, giving people access to reasonably priced medical care and pharmaceuticals. More people can afford prescription drugs thanks to health insurance coverage, which raises the demand for pharmacy goods. As pharmacies grow in importance as healthcare providers, this coverage expansion helps the pharmacy market expand.
Investments are made by governments and healthcare organizations in programs that encourage frequent checkups, a healthy lifestyle, and the early diagnosis of diseases. These activities increase demand for over-the-counter pharmaceutical items as well as vaccines and other preventive drugs. These preventive medications and services are largely provided by pharmacies, which further stimulates the industry. Thus, driving the Pharmacy market revenue.
The Pharmacy Market segmentation, based on product type includes prescription and OTC. The prescription segment dominated the market in 2022. The need for prescription drugs is being driven by the burden of chronic diseases and the aging of the population.
The Pharmacy Market segmentation, based on pharmacy type, includes retail and epharmacy. The retail category generated the most income in 2022. The retail pharmacy industry is being driven by the rise of independent and chain pharmacies, as well as the availability of prescription drugs in mass merchants and supermarkets in nations like the United States and the United Kingdom.
The Pharmacy Market segmentation, based on application, includes hospital-grade and personal use. The hospital-grade segment dominated the market in 2022. In order to address the needs of the large number of patients that healthcare facilities serve, a consistent supply of medications is needed. The hospital-grade segment's dominance is a result of the high demand.
Figure 1: Pharmacy Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Pharmacy Market dominated this market in 2022 (45.80%). The highly developed healthcare systems in North America are highlighted by long-standing hospitals, clinics, and pharmacies. These facilities have cutting-edge medical technology, a contemporary infrastructure, and a knowledgeable staff. The demand for pharmaceutical items has been fueled by the accessibility of advanced healthcare facilities and services. Further, the U.S. Pharmacy market held the largest market share, and the Canada Pharmacy market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: PHARMACY MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Pharmacy market accounts for the second-largest market share. Many European nations offer their citizens complete coverage through well-established universal healthcare systems. A major section of the population will always have access to healthcare services, including prescription drugs, thanks to universal healthcare coverage. The region's demand for pharmaceutical goods is boosted by this extensive coverage. Further, the German Pharmacy market held the largest market share, and the UK Pharmacy market was the fastest growing market in the European region
The Asia-Pacific Pharmacy Market is expected to grow at the fastest CAGR from 2023 to 2032. Chronic diseases like diabetes, cardiovascular diseases, and respiratory ailments are becoming more prevalent in the Asia-Pacific area as a result of rapid urbanization and shifting lifestyles. These ailments necessitate long-term medication treatment, which fuels the demand for pharmaceutical goods and helps the pharmacy sector expand. Moreover, China’s Pharmacy market held the largest market share, and the Indian Pharmacy market was the fastest growing market in the Asia-Pacific region.
Pharmacy Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Pharmacy market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Pharmacy industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Pharmacy industry to benefit clients and increase the market sector. In recent years, the Pharmacy industry has offered some of the most significant advantages to medicine. Major players in the Pharmacy market, including CVS Health, Boots Walgreens, Cigna, Walmart, Kroger, Rite Aid Corp., Lloyd Pharmacy, Well Pharmacy, Humana Pharmacy Solutions, Matsumoto Kiyoshi., and others, are attempting to increase market demand by investing in research and development operations.
Healthcare and retail pharmacy services are provided by CVS Health Corp (CVS Health). The business sells prescription drugs, wellness and healthcare items, cosmetics, and personal care items. Additionally, it provides prescription drug plans, administrative services, Medicaid health care management services, disease management and related services, pharmacy benefit management (PBM) services, and other services. In order to provide prescription medications, pertinent pharmacy advising, and auxiliary services to long-term care homes and other care settings, the company runs long-term care (LTC) pharmacies. The clients of CVS Health include pharmacy benefit managers, sponsors of health benefit plans, insurance companies, unions, public exchanges, and health care programs supported by the government. It advertises its products on retail pharmacy websites, Minute Clinic clinics, onsite pharmacies, and LTC pharmacies. The US state of Rhode Island is home to CVS Health's corporate headquarters.
The health and wellness corporation Humana Inc. (Humana) provides medical and speciality members with access to healthcare benefits. The business provides individuals and employer groups with fully-insured medical and speciality health insurance benefits, such as vision, dentistry, other supplemental health benefits, and administrative services only (ASO) products. Additionally, it provides medical services for veterans, service members who are still on active duty, and their dependents. Predictive modeling and informatics services, clinical care services, provider services, and pharmaceutical solutions are among its offerings. The business offers these goods and services in the US through a network of licensed independent brokers and agents, licensed direct sales representatives, licensed telemarketing representatives, radio and television, direct mail, and the Internet. In the US, Louisville, Kentucky, serves as the home base for Humana.
Key Companies in the Pharmacy market include
Pharmacy Industry Developments
September 2022: Dr. Reddy's Laboratories announced the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market.
June 2022: A 4-in-1 antiretroviral treatment for children living with HIV in South Africa has been made available thanks to a collaboration between Cipla and the Drugs for Neglected Diseases initiative (DNDi).
May 2022: Through one of its wholly owned subsidiaries, Sun Pharmaceutical Industries Limited intends to introduce Bempedoic Acid under the trade name Brillo in India in order to lower low-density lipoprotein (LDL) cholesterol.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1015.5 Billion |
| Market Size 2023 | USD 1062.2 Billion |
| Market Size 2032 | USD 1522.1 Billion |
| Compound Annual Growth Rate (CAGR) | 4.60% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Pharmacy Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | CVS Health, Boots Walgreens, Cigna, Walmart, Kroger, Rite Aid Corp., Lloyd Pharmacy, Well Pharmacy, Humana Pharmacy Solutions, Matsumoto Kiyoshi |
| Key Market Opportunities | Growing health consciousness in the face of the COVID-19 epidemic. |
| Key Market Dynamics | Growing population and increased frequency of chronic diseases will increase need. |
Pharmacy Market Highlights:
Frequently Asked Questions (FAQ) :
The Pharmacy Market size was valued at USD 1015.5 Billion in 2022.
The global market is projected to grow at a CAGR of 4.60% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are CVS Health, Boots Walgreens, Cigna, Walmart, Kroger, Rite Aid Corp., Lloyd Pharmacy, Well Pharmacy, Humana Pharmacy Solutions, and Matsumoto Kiyoshi.
The Prescription category dominated the market in 2022.
The Retail pharmacy had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
